0.1695
4.63%
0.0075
Handel nachbörslich:
.17
0.0005
+0.29%
Finanzdaten der Applied Dna Sciences Inc-Aktie (APDN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
4.32%
0.9296
|
0.8912 | 0.7797 | 2.9173 | 4.4076 |
Cost Of Revenue |
3.95%
0.634
|
0.6601 | 0.7007 | 1.648 | 2.6002 |
Gross Profit |
27.93%
0.2957
|
0.2311 | 0.079 | 1.2693 | 1.8074 |
Operating Expenses
|
2.66%
3.9134
|
4.0202 | 4.2498 | 4.1284 | 4.5115 |
Benefits Costs and Expenses |
168.29%
5.4234
|
2.0214 | 4.3954 | 6.0315 | 3.8564 |
Costs And Expenses |
168.29%
5.4234
|
2.0214 | 4.3954 | 6.0315 | 3.8564 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
4.52%
-3.6178
|
-3.7891 | -4.1708 | -2.8591 | -2.704 |
Net Interest Income/Expense |
53.93%
0.0154
|
0.0333 | 0.0412 | 0.0268 | 0.00364 |
Interest Income/Expense After Provision For Losses |
53.93%
0.0154
|
0.0333 | 0.0412 | 0.0268 | 0.00364 |
Income/Loss From Continuing Operations Before Tax |
297.58%
-4.4938
|
-1.1303 | -3.6157 | -3.1142 | 0.5512 |
Income/Loss From Continuing Operations After Tax |
297.58%
-4.4938
|
-1.1303 | -3.6157 | -3.1142 | 0.5512 |
Net Income/Loss
|
297.58%
-4.4938
|
-1.1303 | -3.6157 | -3.1142 | 0.5512 |
Preferred Stock Dividends And Other Adjustments |
0.1553
|
- | - | - | - |
Attributable To Noncontrolling Interest |
7.43%
-0.0233
|
-0.0252 | -0.0234 | -0.0144 | -0.0372 |
Basic Average Shares |
93.63%
0.8713
|
13.67 | 0.1669 | 12.91 | 12.91 |
Diluted Average Shares |
93.63%
0.8713
|
13.67 | 0.1669 | 12.91 | 12.91 |
Basic Earnings Per Share |
5,800%
-5.31
|
-0.09 | -0.27 | -0.24 | 0.05 |
Diluted Earnings Per Share |
5,800%
-5.31
|
-0.09 | -0.27 | -0.24 | 0.05 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
0.1553
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):